Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192. https://doi.org/10.1002/art.1780370206
Article CAS PubMed Google Scholar
Radice A, Sinico RA (2005) Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 38:93–103. https://doi.org/10.1080/08916930400022673
Article CAS PubMed Google Scholar
Falde SD, Fussner LA, Tazelaar HD et al (2024) Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis. Lancet Rheumatol 6:e314–e327. https://doi.org/10.1016/S2665-9913(24)00035-3
Article CAS PubMed Google Scholar
Arnold S, Kitching AR, Witko-Sarsat V et al (2024) Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis. Lancet Rheumatol 6:e300–e313. https://doi.org/10.1016/S2665-9913(24)00025-0
Article CAS PubMed Google Scholar
Anderson G, Coles ET, Crane M et al (1992) Wegener’s granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. Q J Med 83:427–438
Comarmond C, Cacoub P (2014) Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev 13:1121–1125. https://doi.org/10.1016/j.autrev.2014.08.017
Schirmer JH, Wright MN, Vonthein R et al (2016) Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. Rheumatology (Oxford) 55:71–79. https://doi.org/10.1093/rheumatology/kev286
Guillevin L, Durand-Gasselin B, Cevallos R et al (1999) Microscopic polyangiitis: Clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430. https://doi.org/10.1002/1529-0131(199904)42:3%3c421::AID-ANR5%3e3.0.CO;2-6
Article CAS PubMed Google Scholar
Robson JC, Grayson PC, Ponte C et al (2022) 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis 81:315–320. https://doi.org/10.1136/annrheumdis-2021-221795
Suppiah R, Robson JC, Grayson PC et al (2022) 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis. Arthritis Rheumatol 74:400–406. https://doi.org/10.1002/art.41983
Article CAS PubMed Google Scholar
Ambrogi E, Cavazza A, Smith ML, Graziano P (2024) Pulmonary pathology in vasculitis. Pathologica 116:93–103. https://doi.org/10.32074/1591-951X-988
Hellmich B, Sanchez-Alamo B, Schirmer JH et al (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. https://doi.org/10.1136/ard-2022-223764
Jayne DRW, Merkel PA, Schall TJ, Bekker P (2021) Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med 384:599–609. https://doi.org/10.1056/NEJMoa2023386
Article CAS PubMed Google Scholar
Luqmani RA, Bacon PA, Moots RJ et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87:671–678
Exley AR, Bacon PA, Luqmani RA et al (1997) Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371–380. https://doi.org/10.1002/art.1780400222
Article CAS PubMed Google Scholar
Diagnostics | Free Full-Text | Pulmonary Vasculitides: A Radiological Review Emphasizing Parenchymal HRCT Features. https://www.mdpi.com/2075-4418/11/12/2318. Accessed 17 Jun 2024
Mohammad AJ, Mortensen KH, Babar J et al (2017) Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: The influence of ANCA subtype. J Rheumatol 44:1458–1467. https://doi.org/10.3899/jrheum.161224
Suzuki A, Sakamoto S, Kurosaki A et al (2019) Chest high-resolution CT findings of microscopic polyangiitis: a Japanese first Nationwide prospective Cohort Study. Am J Roentgenol 213:104–114. https://doi.org/10.2214/AJR.18.20967
Tzelepis GE, Kokosi M, Tzioufas A et al (2010) Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 36:116–121. https://doi.org/10.1183/09031936.00110109
Article CAS PubMed Google Scholar
Cozzi D, Cavigli E, Moroni C et al (2021) Ground-glass opacity (GGO): a review of the differential diagnosis in the era of COVID-19. Jpn J Radiol 39:721–732. https://doi.org/10.1007/s11604-021-01120-w
Article CAS PubMed PubMed Central Google Scholar
Kida T, Tanaka T, Yokota I et al (2020) Association between preexisting lung involvements and the risk of diffuse alveolar hemorrhage in patients with microscopic polyangiitis: A multi-center retrospective cohort study. Mod Rheumatol 30:338–344. https://doi.org/10.1080/14397595.2019.1601855
Hogan SL, Nachman PH, Wilkman AS et al (1996) Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7:23. https://doi.org/10.1681/ASN.V7123
Article CAS PubMed Google Scholar
Pagnoux C, Hogan SL, Chin H et al (2008) Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Arthritis Rheum 58:2908–2918. https://doi.org/10.1002/art.23800
Article PubMed PubMed Central Google Scholar
Hogan SL, Falk RJ, Chin H et al (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143:621–631. https://doi.org/10.7326/0003-4819-143-9-200511010-00005
Walsh M, Flossmann O, Berden A et al (2012) Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheum 64:542–548. https://doi.org/10.1002/art.33361
Article CAS PubMed Google Scholar
Salmela A, Törnroth T, Poussa T, Ekstrand A (2018) Prognostic factors for survival and relapse in ANCA-associated vasculitis with renal involvement: a clinical long-term follow-up study. Int J Nephrol. https://doi.org/10.1155/2018/6369814
Article PubMed PubMed Central Google Scholar
Seo P, Min Y-I, Holbrook JT et al (2005) Damage caused by Wegener’s granulomatosis and its treatment: Prospective data from the Wegener’s Granulomatosis Etanercept Trial (WGET). Arthritis Rheum 52:2168–2178. https://doi.org/10.1002/art.21117
Article CAS PubMed Google Scholar
Koldingsnes W, Nossent H (2002) Predictors of survival and organ damage in Wegener’s granulomatosis. Rheumatology 41:572–581. https://doi.org/10.1093/rheumatology/41.5.572
Article CAS PubMed Google Scholar
Russell B, Mohan S, Chahal R et al (2018) Prognostic significance of cavitary lung nodules in granulomatosis with polyangiitis (Wegener’s): a clinical imaging study of 225 patients. Arthritis Care Res (Hoboken) 70:1082–1089. https://doi.org/10.1002/acr.23443
Alba MA, Flores-Suárez LF, Henderson AG et al (2017) Interstital lung disease in ANCA vasculitis. Autoimmun Rev 16:722–729. https://doi.org/10.1016/j.autrev.2017.05.008
Article PubMed PubMed Central Google Scholar
Borie R, Crestani B (2018) Antineutrophil cytoplasmic antibody-associated lung fibrosis. Semin Respir Crit Care Med 39:465–470. https://doi.org/10.1055/s-0038-1669914
Hozumi H, Oyama Y, Yasui H et al (2018) Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias. PLoS One 13:e0199659.
Comments (0)